XMEX
CYDSASAA
Market cap505mUSD
Dec 02, Last price
17.35MXN
1D
0.00%
1Q
0.87%
Jan 2017
-27.10%
Name
Cydsa SAB de CV
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cydsa, S.A.B. de C.V., together its subsidiaries, engages in the production and marketing of salt, chlorine, caustic soda, and refrigerant gases in Mexico, the United States, Canada, Central and South America, Asia, and Europe. It operates through Salt, Chlorine and Caustic Soda, Refrigerant Gases, and Energy Processing and Logistics segments. The company offers light salt, salt substitute, Kosher and halal grade salt, salt with chili and lime, and coarse sea salt for use in household and commercial human consumption, food industry, and industrial processes. It also provides chlorine, liquid and gas, chlorine in cylinders, sodium hypochlorite, caustic potash, synthetic hydrochloric acid, and muriatic acid, as well as liquid, solid, and rayon and membrane grade caustic soda for use in chemical and petrochemical industries, water treatment, oils, cellulose, papers, bottling, pesticides, bleaches, detergents and soaps, plastics, pigments, paints, and mining and extraction of metals. In addition, the company offers refrigerant, propellant, and blowing gases, as well as gases for fluoropolymers and anesthetic medical products for use in industrial, commercial and domestic refrigeration, home appliances, and pharmaceutical industries. Further, it is involved in the electricity and steam cogeneration business; and hydrocarbons processing and underground storage business, as well as provides liquid petroleum gas storage services. The company offers its products under the La Fina, Cisne, Marfil, Gallo, Palomitos, Bakará, Elefante, Klara, Carmen, Brisa de Occidente, Genetron, Aquion, and Eco Flush trademarks. Cydsa, S.A.B. de C.V. was founded in 1945 and is headquartered in Monterrey, Mexico.
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||